1. What the law is
Possession for personal use is a criminal offense in Denmark, carrying up to 2 years' imprisonment under the Euphoriants Act. The listing reaches past the compound: mushrooms and their spores have been named euphoriant substances since an executive order of 21 June 2001, which added them as a single entry covering cultivated, dried or otherwise processed material, and that wording has carried unchanged into the order in force today. Research use needs authorization from the Medicines Agency. There is no medical or therapeutic access program.
2. Trials in Denmark
Interventional psilocybin trials with at least one site in Denmark, as their sponsors filed them with ClinicalTrials.gov, EU CTIS and ISRCTN. Each row links to the registry record, which sets out who may take part.
Recruiting or opening counts trials recruiting now, not yet recruiting, or enrolling by invitation. Closed counts trials terminated, suspended, withdrawn or left unverified by their sponsors.
| Registry ID | Trial | Phase | Sponsor | Status | Start date |
|---|---|---|---|---|---|
| NCT03289949 | The Neurobiological Effect of 5-HT2AR Modulation (opens in new tab)Recruiting at Neurobiology Research Unit, Rigshospitalet, Copenhagen | Phase Phase 1 | Sponsor Gitte Moos Knudsen | Status Recruiting | Start date |
| NCT06782724 | Psilocybin Therapy for Psychological Distress in Palliative Patients (opens in new tab)Recruiting at Bispebjerg Hospital, Copenhagen | Phase Phase 2 | Sponsor University Medical Center Groningen | Status Authorised | Start date |
| 2023-503617-30-02 | Boosting recovery through excitation of arousal and awareness in comatose patients: Dose finding study (BREA2KTHROUGH DOSEFINDER) (opens in new tab)Sites in Copenhagen Nv, Copenhagen Oe, Glostrup | Phase Not stated | Sponsor Rigshospitalet | Status Authorised | Start date |
| 2023-505268-12-00 | A Phase III, multicentre, randomised, double-blind, controlled study to investigate the efficacy, safety, and tolerability of two initial administrations of COMP360 in participants with treatment-resistant depression (opens in new tab)Site at Region Nordjylland, Aalborg | Phase Not stated | Sponsor Compass Pathfinder Limited | Status Authorised | Start date |
| 2024-517497-17-01 | Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial. (opens in new tab)Site at Psykiatrisk Center Kobenhavn, Copenhagen Oe | Phase Not stated | Sponsor Region Hovedstaden | Status Ended | Start date |
| NCT05416229 | Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder (opens in new tab)Site at Psychiatric Center Copenhagen, Frederiksberg Hospital, Frederiksberg | Phase Phase 2 | Sponsor Anders Fink-Jensen, MD, DMSci | Status Completed | Start date |
| NCT05711940 | Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD (opens in new tab)Site at Aalborg Universitetshospital-Psykiatrien Region Nordjylland, Aalborg | Phase Phase 3 | Sponsor COMPASS Pathways | Status Active, not recruiting | Start date |
| NCT04718792 | Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study (opens in new tab)Site at Psychiatric Center Copenhagen, Copenhagen | Phase Phase 2 | Sponsor Anders Fink-Jensen, MD, DMSci | Status Unknown status | Start date |
| NCT04280055 | Prophylactic Effects of Psilocybin on Chronic Cluster Headache (opens in new tab)Site at Neurobiology Research Unit, Rigshospitalet, Copenhagen | Phase Phase 1/2 | Sponsor Gitte Moos Knudsen | Status Terminated | Start date |
| NCT03775200 | The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression (opens in new tab)Site at Enhed for Psykiatrisk Forskning, Psykiatrien i Aalborg, Aalborg | Phase Phase 2 | Sponsor COMPASS Pathways | Status Completed | Start date |
| 2025-522961-31-01 | The Acute and Long-term Impact of Support in Psilocybin Therapy for Depression: The Psilocybin Setting Trial (PSISET) (opens in new tab)Site at Koebenhavns Universitet, Copenhagen K | Phase Not stated | Sponsor Kobenhavns Universitet, Koebenhavns Universitet | Status Authorised | Start date Not stated |
| 2025-524939-39-02 | The Danish Anorexia Nervosa Psilocybin RCT (DANP-RCT). A Randomised, Active-Placebo-Controlled, Triple-blind, Superiority Study of Psilocybin-Assisted Acceptance and Commitment Therapy (ACT) in the Treatment of Treatment-resistant Anorexia Nervosa. (opens in new tab)Site at Region Sjaelland, Roskilde | Phase Not stated | Sponsor Slagelse Hospital | Status Authorised | Start date Not stated |
ClinicalTrials.gov data courtesy of the U.S. National Library of Medicine.
3. History
The legal events behind this entry, dated and oldest first. Our own reviews and corrections are listed under Changes to this record.
No reform legislation on file for Denmark yet. If one passes, it appears here, dated.
4. Proposed laws
Proposals that are not yet law and would change this entry if adopted.
Nothing is before the Folketing as of 16 Aug 2026, on a search of the Folketing's own case register that day for psilocybin and psychedelic terms. The most recent item was B 5 in the 2025-26 session, a resolution proposal to set up a cross disciplinary working group to map and assess how psychedelic substances might be regulated from a public health perspective. It lapsed when the session closed on 24 Mar 2026 and was never voted on. Clinical trials continue at Copenhagen (NRU and Rigshospitalet) and Aalborg university hospitals.
5. Common questions
Is psilocybin legal in Denmark?
Psilocybin is illegal in Denmark.
Are magic mushrooms ("shrooms") legal in Denmark?
"Magic mushrooms" and "shrooms" are common names for fungi that contain psilocybin, and this entry states the law on psilocybin itself, which some laws treat separately from the fungus. Psilocybin is illegal in Denmark.
Read the law
Lov om euforiserende stoffer (Euphoriants Act), consolidated as lovbekendtgorelse nr. 1334 of 9 December 2019, section 2(4): import, export, sale, purchase, supply, receipt, manufacture, processing and possession of listed substances are forbidden, and section 3 sets a fine or imprisonment of up to 2 years. Mushrooms entered the lists by BEK nr. 587 of 21 June 2001 (in force 1 July 2001), which inserted into list B of annex 1 to the 1993 order a new no. 132 a covering mushrooms and spores of Psilocybe semilanceata, Psilocybe cubensis and any other mushrooms or spores containing psilocin or psilocybin, including cultivated, dried or otherwise processed material. That entry has been carried forward unchanged through every reissue since, among them BEK nr. 557 of 31 May 2011, which this record cited as current until August 2026 and which was itself superseded in 2020, 2021 and 2026. The order in force is Bekendtgorelse om euforiserende stoffer (BEK nr. 405 of 26 March 2026, in force 29 March 2026), issued under section 1(1) and (2) and section 2(1) and (2) of the Act, which repealed BEK nr. 2446 of 12 December 2021 and lists at list B of annex 1: no. 407 psilocin, no. 408 psilocybin, and no. 411 mushrooms and spores. Lists B, D and E cover substances usable only for medical and scientific purposes.1
Sources
This entry's status is checked against the primary sources below, and the methodology explains how each entry is graded for confidence.
- 1.laegemiddelstyrelsen.dk (opens in new tab) · laegemiddelstyrelsen.dk
- 2.European Union Drugs Agency.European Union Drugs Agency (opens in new tab) · euda.europa.eu
This entry is for information only and is not legal or medical advice. Laws change, and enforcement can differ from the letter of the law, so check the current position against the primary sources above before relying on it.
Changes to this record
3 changes on file, the latest on . Show allHide
Every change we have made to this record, dated, corrections included. Nothing changes silently.
Denmark's entry pointed at an executive order that stopped being current in 2020. The order in force is now cited, and the listing itself is unchanged: mushrooms and their spores have been controlled since 2001.
Denmark's entry said no bill was pending. A resolution proposal on psychedelics, B 5, had in fact been tabled and then lapsed when the session ended in March 2026, and the entry now records it. The list of banned substances also covers spores, which the entry had not mentioned.
Denmark had been recorded as mixed, which overstated the position. Possession is criminal, the only exceptions are for research, and no medical program exists, so the status moves to illegal.
Psilocybin Media Group. "Denmark: psilocybin legal status." The Psilocybin Record, accession DK-001, version of 23 Aug 2026. https://psilocybinlegalization.com/record/denmark